A Multicentre, Large-Scale, Observational Study of Tocilizumab in Patients with Takayasu Arteritis in Japan: The ACT-Bridge Study.

Masayoshi HarigaiTakako MiyamaeHideyuki HashimotoAmika YoshidaKatsuhisa YamashitaYoshikazu Nakaoka

Published in: Modern rheumatology (2022)

This study demonstrated the effectiveness of tocilizumab in patients with TAK, with no new safety concerns. Tocilizumab plus glucocorticoids may be considered a treatment option for TAK.

Keyphrases

rheumatoid arthritis
juvenile idiopathic arthritis
randomized controlled trial
rheumatoid arthritis patients
systematic review
clinical trial
study protocol
cross sectional
combination therapy
smoking cessation